XML 41 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Information
3 Months Ended
Mar. 31, 2014
Segment Information [Abstract]  
Segment Information
(12)
Segment Information

We have two operating groups which constitute reportable operating segments: Merge Healthcare and Merge DNA.  We evaluate the performance of these operating groups based on their respective revenues and operating income, which exclude public company costs, certain corporate costs (amortization expense that is not specific to a segment), net interest expense and income taxes.

The following tables present operating group financial information for the periods indicated:
 
 
 
Three Months Ended March 31, 2014
 
 
 
Healthcare
  
DNA
  
Total
 
Net sales:
 
  
  
 
Software and other
 
$
11,142
  
$
3,941
  
$
15,083
 
Professional services
  
7,076
   
3,413
   
10,489
 
Maintenance and EDI
  
25,011
   
320
   
25,331
 
Total net sales
  
43,229
   
7,674
   
50,903
 
Expenses
  
37,213
   
6,886
   
44,099
 
Segment income
 
$
6,016
  
$
788
   
6,804
 
 
            
Net corporate/other expenses (1)
          
6,498
 
Income (loss) before income taxes
         
$
306
 

 
 
Three Months Ended March 31, 2013
 
 
 
Healthcare
  
DNA
  
Total
 
Net sales:
 
  
  
 
Software and other
 
$
17,825
  
$
5,746
  
$
23,571
 
Professional services
  
8,055
   
4,068
   
12,123
 
Maintenance and EDI
  
27,358
   
582
   
27,940
 
Total net sales
  
53,238
   
10,396
   
63,634
 
Expenses
  
44,151
   
10,564
   
54,715
 
Segment income (loss)
 
$
9,087
  
$
(168
)
  
8,919
 
 
            
Net corporate/other expenses (1)
          
12,397
 
Loss before income taxes
         
$
(3,478
)
 
(1)  Net corporate/other expenses include public company costs, corporate administration expenses, amortization expense which is not attributable to business segments, acquisition-related expenses and net interest expense.
 
 
 
Healthcare
  
DNA
  
Corporate/ Other
  
Consolidated
 
Depreciation and amortization
 
  
  
  
 
 
 
  
  
  
 
Three Months ended March 31, 2014
 
$
3,282
  
$
793
  
$
2
  
$
4,077
 
 
                
Assets as of March 31, 2014
 
$
322,115
  
$
41,972
  
$
5,466
  
$
369,553
 

 
 
Healthcare
  
DNA
  
Corporate/ Other
  
Consolidated
 
Depreciation and amortization
 
  
  
  
 
 
 
  
  
  
 
Three Months ended March 31, 2013
 
$
3,401
  
$
1,046
  
$
16
  
$
4,463
 
 
Restructuring and Other One Time Charges
                
 
                
Three Months ended March 31, 2013
 
$
1,229
  
$
-
  
$
-
  
$
1,229
 
 
                
Assets as of December 31, 2013
 
$
333,459
  
$
42,894
  
$
5,728
  
$
382,081